EP0051707A1 — Dextran polycarboxylic acids, ferric hydroxide complexes thereof, pharmaceutical compositions containing them and methods for their manufacture
Assigned to Individual · Expires 1982-05-19 · 44y expired
What this patent protects
Novel dextran polycarboxylic acids and their ferric hydroxide complexes are described as well as methods for their preparation. The novel dextran polycarboxylic acid polymers are characterised by carboxylic acid groups preferably 2-10 in number located in pairs on intermediate gl…
USPTO Abstract
Novel dextran polycarboxylic acids and their ferric hydroxide complexes are described as well as methods for their preparation. The novel dextran polycarboxylic acid polymers are characterised by carboxylic acid groups preferably 2-10 in number located in pairs on intermediate glycosyl units in the polymer chain. The novel polymers are prepared by mild oxidation of a dextran or hydrogenated dextran to produce intermediate aldehyde groups and subsequent conversion of the aldehyde groups to carboxylic acid groups by further oxidation or by cyanidation and hydrolysis. Parenterally administrable compositions containing the ferric hydroxide complexes are also covered.
Drugs covered by this patent
- Injectafer (FERRIC CARBOXYMALTOSE) · Am Regent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.